SquamousCellCarcinomaofSkin near Brooksville, FL

Care Philosophy: Dr Jaglal completed his hematology/oncology fellowship at the University of South Florida and Moffitt Cancer Center. His research interests are in benign hematologic disorders: hemophilia, von Willebrand's disease, anemias, hemostasis and thrombosis disorders. Clinically, Dr Jaglal is a hematologist/oncologist and member of Moffitt Medical Group in the Satellite and Community Oncology Department practicing at Tampa General Hospital and Moffitt international Plaza. The MMG faculty at TGH provides invaluable oncology services to the large patient population of this leading regional hospital.

Biography: Dr. Aaron Denson, MD is an Oncology Specialist who practices in Brooksville, FL. He is 39 years old and has been practicing for 20 years. Dr. Aaron Denson, MD is affiliated with HCA Florida Oak Hill Hospital.

Care Philosophy: Dr Celeste Bello isa double board-certified hematologist and medical oncologist, and a senior member in the Malignant Hematology program at Moffitt Cancer Center. She joined the faculty at Moffitt Cancer Center in 2008 after completing her fellowship at the University of South Florida. Dr Bello has developed special expertise in managing patients with Hodgkin's and non-Hodgkin's lymphomas, a special category within the broader group of hematologic (blood) malignancies. Examples of non-Hodgkin's lymphomas include follicular lymphoma, marginal zone lymphoma, small lymphocytic lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma.

Care Philosophy: Dr Creelan earned his MD from Jefferson Medical College. He completed an Internal Medicine Residency at Thomas Jefferson University in the Department of Internal Medicine. Dr Creelan then completed a Hematology Oncology Fellowship at the University of South Florida at Moffitt Cancer Center anda Master's Degree in Clinical and Translational Research through the National Institute of Health K30-sponsored SPOR program. Dr Creelan will focus on translational and clinical research, specifically the development of new immune therapies, for the treatment of lung cancers. His research efforts aim to more effectively treat these cancers based on new insights into the biology of the disease.